Kelvin A. Moses, MD, PhD

15 Pages·2014·0.13 MB·English

August 4, 2014

Kelvin A. Moses, MD, PhD
Vanderbilt University Medical Center
Department of Urologic Surgery
A-1302 MCN
Nashville, TN 37232
615-343-1317

[email protected]

Citizenship: United States

Birthplace: Alexandria, Virginia

Birthdate: July 25, 1974

Languages Spoken: English, Spanish

Licensure: New York State License #256150, Inactive
Georgia State License #67512, Active
Tennessee State License #50749, Active

Board Certification: Part I, Passed August 2010
Part II, Pending

Education:
1992 Indian River High School, Chesapeake, VA
1996 B.S., Chemistry, Magna Cum Laude, Morehouse College, Atlanta, GA
Minor Concentration, Spanish
2003 Ph.D., Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX
Thesis Title: Unlocking the Nkx Code: Using the Nkx 3.2-Cre Mouse Model to
Understand Nkx Interactions In Vivo
Advisor: Robert J. Schwartz, PhD
2004 M.D., Baylor College of Medicine, Houston, TX
August 4, 2014

Postgraduate Training:
2005-2006 Internship, General Surgery
Department of Surgery, Emory University School of Medicine
Chairman: William C. Wood, M.D.

2006-2009 Resident, Urology
Department of Urology, Emory University School of Medicine
Chairman: Fray F. Marshall, M.D.

2009-2010 Chief Resident, Urology
Department of Urology, Emory University School of Medicine
Chairman: Fray F. Marshall, M.D.

2010-2011 Fellow, Urologic Oncology
Department of Surgery, Memorial Sloan-Kettering Cancer Center
(Chief Administrative Fellow July-December 2011)
Chairman: Peter T. Scardino, M.D. Chief: James A. Eastham, M.D.

Faculty Positions:
Jan 2014-Present Assistant Professor of Urology, Department of Urologic Surgery
Vanderbilt University, Nashville, TN
March 2014-Present Chief of Urology, Nashville General Hospital, Nashville, TN
March 2014-Present Member, Vanderbilt-Ingram Cancer Center
April 2012- Dec 2013 Assistant Professor of Urology, Division of Urology, Department of
Surgery Medical College of Georgia at Georgia Regents University
Augusta, GA
June 2012-Dec 2013 Chief of Urology, Augusta VA Medical Center, Augusta, GA
May 2012-Dec 2013 Member, Georgia Regents University Cancer Center, Augusta, GA

Committee Memberships:
April 2012-Dec 2013 Protocol Review and Monitoring Committee, GRU Cancer Center
July 2013-Dec 2013 Faculty Senate Committee on Committee, GRU
Jan 2014 Nashville General Hospital OR Committee
March 2014 Nashville General Hospital Cancer Committee

Teaching Experience:
2013-Present Basics of Urology, Meharry Medical College Surgery Student Lecture
2012-2013 Resident Education, Oncology Lectures and Preoperative Conference, GRU
2001-2003 Basics of Biomedical Science, Introductory Lecture for Course in Biotechnology
Law, University of Houston School of Law
2001-2002 Instructor in Gross Anatomy, Rice/Baylor Honors Premedical Academy
1998-2002 Teaching Assistant and Tutor, Gross Anatomy, Baylor College of Medicine
1998-2000 Instructor, Surgical Skills for Pre-Clinical Students, Baylor College of Medicine
August 4, 2014

Volunteer/Community Outreach Experience:
2012 UsToo Prostate Cancer Support Group
2010 Guest speaker at several Atlanta area churches, “Prostate Cancer Screening”
2007 National Prostate Cancer Coalition prostate cancer screening, Family Day
of Unity in conjunction with the Louis Farrakhan Prostate Cancer Foundation
1998 Hospital General del Estado “Dr. Jesùs Kumate Rodríguez”, Medical Student
Internship, Cancùn, Q. Roo, Mexico
1997 Baptist Medical Student Mission, Ciudad Acuña, Coahuila, Mexico
1993 Hospital General “Aurelio Valdivieso”, Oaxaca, Oaxaca, Mexico, Morehouse-
Spelman Summer Exchange Program

Professional Memberships:
2012-Present Society of Urologic Oncology
2012-2013 Georgia Urological Association
2008-Present National Medical Association
2006-Present American Association of Clinical Urologists
2005-Present American Urological Association
2005-Present Endourological Society
2005-2010 American College of Surgeons
2005-2010 Board of Advisors, Atlanta Area National Youth Leadership Forum on
Medicine
1998-2005 American Society for Cell Biology
1997-2005 Faculty Advisor and Member, Board of Advisors, Houston-Galveston
Area National Youth Leadership Forum
1996-2005 Student National Medical Association

Officer and Committee Assignments:
2013 Ad hoc Abstract Reviewer, Southeastern Section of the American Urological
Association
March 2014 Moderator, Renal Cancer Poster Session, 78th Annual Meeting Southeastern
Section of the AUA

Honorary Society Memberships:
Alpha Omega Alpha- Faculty
Phi Beta Kappa
Beta Kappa Chi
Sigma Delta Gamma
Golden Key National Honor Society
August 4, 2014

Awards:
2013 AUA/SBU Academic Exchange Program Award
2013 AUA Urological Oncology Symposium Travel Award
2013 Medical College of Georgia Exemplary Teaching Award
2010 Outstanding Academic Achievement, Top Research Resident
Emory University Department of Urology
2009 ASCO Resident Travel Award
2009 First Place, Resident Research Presentation, 6th Annual Georgia Urological
Association Spring Meeting
2008 UCSF CaPSURETM Scholar
2008 NIH/NMA Travel Award, NMA National Convention
2008 IVUmed Resident Scholarship, Tapachula, Mexico
2008 First Place, Resident Case Report, 5th Annual Georgia Urological Association
Spring Meeting
2008 Third Place, Resident Research Presentation, 5th Annual Georgia Urological
Association Spring Meeting
2003 Outstanding Graduate Student, Graduate School of Biomedical Sciences, Baylor
College of Medicine
2002 National Award Winner, Minority Trainee Research Forum
2001 Minority Affairs Committee Travel Award, American Society for Cell Biology
2001 Minority Travel Award, M.D./Ph.D. Student Symposium
1997 Robert C. McNair Foundation Scholar, Baylor College of Medicine Medical
Scientist Training Program

Prior Research Funding:
2001-2003 UNCF/Merck Pharmaceuticals Graduate Research Fellowship
(Grant Support: $42,000/year)

Reviewer, Peer-reviewed Journals:
American Journal of Public Health
British Journal of Cancer
BJU International
Endocrine Research
Journal of Andrology and Gynaecology- Editorial Board
Journal of Endourology
Journal of Immigrant and Minority Health
Journal of Urology
Prostate Cancer and Prostatic Diseases (PCAN)
Tumor Biology
Urologic Oncology
August 4, 2014

Residents and Students Mentored:

Students
Lael Reinstatler, Medical College of Georgia
Brittani Barrett, Medical College of Georgia
Christine Ibilibor, Medical College of Georgia
Junjian Huang, Medical College of Georgia

Residents
Lindsey Herrel, Emory
S. Mohammed Jafri, Emory
Derek Prabharasuth, New York Medical College
John Sfakianos, SUNY Downstate
Andrew Winer, SUNY Downstate
Sherita King, Medical College of Georgia
Zachary Klaassen, Medical College of Georgia
Qiang Li, Medical College of Georgia

PhD Candidates- Thesis Committee Member
Ahmed Al-Azayzih, University of Georgia

Abstracts (Regional and National):
1. Moses KA, DeMayo F, Zimmer WE, and Schwartz RJ. Expression og Nkx 3.2 in Mouse
Using Cre-Lox Recombination. M.D./Ph.D. National Student Symposium, 2001.

2. Moses KA, DeMayo F, Zimmer WE, and Schwartz RJ. Expression of Nkx 3.2 in Mouse
Using Cre-Lox Recombination. 41st Annual Meeting of The American Society for Cell Biology,
2001.

3. Moses KA, Zimmer DB, Zimmer WE, and Schwartz RJ. In Vivo Analysis of Nkx 3.2 in
Mouse. Minority Trainee Research Forum. (Poster and Oral Presentation), 2002.

4. Moses KA, Stanfel MN, Zimmer DB, Zimmer WE, and Schwartz RJ. The bagpipe
homologue, Nkx 3.2, is an Important Regulator of Mesodermal Development. Mouse Molecular
Genetics Meeting, Cold Spring Harbor Laboratories, 2002.

5. Moses KA, Stanfel MN, Zimmer DB, Zimmer WE, and Schwartz RJ. The bagpipe
homologue, Nkx 3.2, is an Important Regulator of Mesodermal Development. 42nd Annual
Meeting of The American Society for Cell Biology, 2002.

6. Moses KA. Scrotal Lesion in an HIV+ Male. 4th Annual Georgia Urological Association
Meeting, February, 2007.
August 4, 2014

7. Moses KA and Issa MM. A Case Study of Flank Fistula in an Elderly Male. 4th Annual
Georgia Urological Association Meeting, February 2007.

8. Moses KA and Ritenour CWM. UTI and Urinary Retention in a 36-year-old Woman. 5th
Annual Georgia Urological Association Meeting, February 2008.

9. Moses KA, Adibi M, Petros JA, Issa MM, and Ritenour CWM. First Time Urolithiasis in
Patients ≥75 Years of Age. 5th Annual Georgia Urological Association Meeting, February 2008.

10. Moses KA, Abd TT, Hall JA, Goodman M, Petros JA, Marshall FF, and Issa, MM. Elevated
LDL is Associated with an Increased Risk of Prostate Cancer in African-Americans. 5th Annual
Georgia Urological Association Meeting, February 2008.

11. Moses KA, Abd TT, Hall JA, Goodman M, Petros JA, Marshall FF, and Issa, MM. Elevated
LDL is Associated with an Increased Risk of Prostate Cancer in African-Americans. American
Urological Association, Southeastern Section Meeting, March 2008.

12. Moses KA, Adibi M, Petros JA, Issa MM, and Ritenour CWM. First Time Urolithiasis in
Patients ≥75 Years of Age. American Urological Association, Southeastern Section Meeting,
March 2008.

13. Moses KA, Abd TT, Hall JA, Goodman M, Petros JA, Marshall FF, and Issa, MM. Elevated
LDL is Associated with an Increased Risk of Prostate Cancer in African-Americans. American
Urological Association Meeting, May 2008.

14. Moses KA, Abd TT, Hall JA, Goodman M, Petros JA, Marshall FF, and Issa, MM. Elevated
LDL is Associated with an Increased Risk of Prostate Cancer in African-Americans. National
Medical Association Annual Meeting, July 2008.

15. Moses KA and Carney KJ. Young man with frequent UTI. 6th Annual Georgia Urological
Association Meeting, February 2009.

16. Moses KA, Paciorek AT, Penson DF, Carroll PR, and Master VA. Impact of race,
comorbidities, perception of general health and risk classification on choice of treatment in men
with prostate cancer: CaPSURE data. 6th Annual Georgia Urological Association Meeting,
February 2009.

17. Moses KA, Hsiao W, Herrel L, White HL, and Master VA. Race does not predict renal
insufficiency after nephrectomy in hypertensive patients. 6th Annual Georgia Urological
Association Meeting, February 2009.

18. Hsiao W, Moses KA, Hawes J, Okafor HT, and Galloway NTM. Anatomic repair of vaginal
wall prolapse without mesh is associated with lasting improvement in urinary quality of life.
American Urological Association, Southeastern Section Meeting, March 2009.
August 4, 2014

19. Moses KA, Paciorek AT, Penson DF, Carroll PR, and Master VA. Impact of race,
comorbidities, perception of general health and risk classification on choice of treatment in men
with prostate cancer: CaPSURE data. American Urological Association Meeting, April 2009.

20. Moses KA, Hsiao W, Young AN, Carney KJ, and Master VA. Metastatic prostate cancer:
clinical characteristics and cost of treatment of unscreened men at a county hospital. 7th Annual
Georgia Urological Association Meeting. February 2010.

21. Moses KA, Tu H, Saint-Elie D, Kapp BB, Issa MM, Goodman M, and Ritenour CWM.
Clinical characteristics of elderly patients with nephrolithiasis. 7th Annual Georgia Urological
Association Meeting, February 2010.

22. Moses KA, Tu H, Saint-Elie D, Kapp BB, Issa MM, Goodman M, and Ritenour CWM.
Clinical characteristics of elderly patients with nephrolithiasis. American Urological
Association, Southeastern Section Meeting, March 2010.

23. Moses KA, Oliva IV, Osunkoya AO, and Carney KJ. Enlarging abdominal mass. T. Leon
Howard Pyelogram Hour. American Urological Association, Southeastern Section Meeting,
March 2010.

24. Master VA, Jafri SMA, Moses KA, Ogan K, Kooby DA, and Delman K. Endoscopic groin
dissection: assessment of perioperative complications and nodal yield. American Urological
Association Meeting, June 2010.

25. Moses KA, Winer A, Sfakianos JP, Bernstein M, and Dalbagni G. Contemporary
management of penile cancer: 15 year experience. American Urological Association Meeting,
May 2012.

26. Prabharasuth D, Moses KA, Bernstein M, Dalbagni G, and Herr HW. Contemporary
management of renal transplant patients diagnosed with urothelial carcinoma of the bladder.
American Urological Association Meeting, May 2012.

27. Dalbagni G, Poon S, Glickman L, Moses KA, Russo P, Donat SM, Herr HW, and Bochner
BH. Contemporary outcomes with primary male urethral carcinoma. American Urological
Association Meeting, May 2012.

28. Prabharasuth D, Moses K, Bernstein M, Dalbagni G, and Herr H. Bladder cancer after renal
transplantation. 24th International Congress of the Transplantation Society, July 2012.

29. Prabharasuth D, Moses K, Bernstein M, Herr H, and Dalbagni G. Radical cystectomy and
urinary diversion after renal transplantation. 24th International Congress of the Transplantation
Society, July 2012.

30. Klaassen Z, Tatem A, Patil S, Madi R, Terris MK, and Moses KA. Patients with multiple
sclerosis have an increased incidence of prostate cancer: a population based analysis. Society of
Urologic Oncology Meeting, November 2012.
August 4, 2014

31. Klaassen Z, Tatem A, Patil S, Madi R, Terris MK, and Moses KA. Prostate cancer incidence
in patients with discoid and systemic lupus erythematosus: a population based analysis. Society
of Urologic Oncology Meeting, November 2012.

32. Li Q, Burnette J, Zheng M, Coulson H, Savage N, Sharma S, Moses K, Terris MK, Madi R.
Urothelial Carcinoma with Multiple Variant Differentiations, Clinical Behavior of a Rare but
very Aggressive Subtype Poster Presentation. Society of Urologic Oncology Meeting, November
28-30, 2012.

33. Klaassen Z, Tatem AJ, Patil S, Madi R, Terris MK, and Moses KA. Incidence of prostate
cancer in patients with autoimmune diseases. 11th Annual Georgia Urological Association
Meeting, March 2013.

34. Klaassen Z, King SA, Tatem AJ, Muller R, Freedland SJ, Terris MK, and Moses KA. Impact
of marital status and comorbidity in men referred for prostate biopsy with PSA >20ng/ml. 11th
Annual Georgia Urological Association Meeting, March 2013.

35. Li Q, Shah SR, Moses KA, and Terris MK. The association of tissue levels of dioxin after
Agent Orange exposure and risk of biochemical recurrence after radical prostatectomy. 11th
Annual Georgia Urological Association Meeting, March 2013.

36. Li Q, Sharma S, Ramalingam P, Moses KA, and Terris MK. Luteinizing hormone-releasing
hormone (LHRH) expression in male meningiomas-implications for coexisting prostate cancer
with LHRH agonists. 11th Annual Georgia Urological Association Meeting, March 2013.

37. Barrett B, Klaassen Z, Franken A, and Moses KA. Multiple discordant renal pathology: a
report of three cases. 11th Annual Georgia Urological Association Meeting, March 2013.

38. Tatem A, Klaassen Z, Botta S, Moses KA, and Terris MK. Beyond urothelial carcinoma: a
two patient case series. 11th Annual Georgia Urological Association Meeting, March 2013.

39. Klaassen Z, Tatem AJ, Patil S, Madi R, Terris MK, and Moses KA. Prostate cancer
incidence in patients with autoimmune disease with primarily cutaneous manifestations: a
population based analysis. American Urological Association, Southeastern Section Meeting,
March 2013.

40. Li Q, Shah SR, Lan L, Moses KA, and Terris MK. High tissue level of dioxin-TEQ is
associated with Agent Orange exposure and poor biochemical recurrence free survival after
radical prostatectomy. American Urological Association, Southeastern Section Meeting, March
2013.

41. Klaassen Z, Kohut Jr RM, Patel D, Moses KA, Shingleton WB, Terris MK, and Madi R.
Does the approach matter? A single surgeon’s experience with open, laparoscopic and robotic
partial nephrectomy. American Urological Association, Southeastern Section Meeting, March
2013.
August 4, 2014

42. Li Q, Shah SR, Lan L, Moses KA, Teris MK. The High Tissue Level of Dioxin-TEQ Is
Associated with Agent Orange Exposure and Poor Biochemical Recurrence Free Survival after
Radical Prostatectomy. VA Urologists AUA Forum. American Urological Association Meeting,
May 2013.

43. Klaassen Z, Tatem A, Patil S, Madi R, Terris MK, Moses KA. Prostate Cancer Incidence in
Patients with Autoimmune Diseases: A Population Based Analysis. American Urological
Association Meeting, May 2013.

44. Klaassen Z, Huang J, King SA, Li Q, Shingleton BW, Moses KA, Terris MK, and Madi R.
Salvage robotic partial nephrectomy: a viable approach for management of local tumor
recurrence following failed nephron sparing surgery. 31st World Congress of Endourology and
SWL, New Orleans, LA, October 23, 2013.

45. Huang J, Klaassen Z, Li Q, Shingleton BW, Moses KA, Terris MK, and Madi R. A
comparison of laparoscopic versus robotic partial nephrectomy perioperative outcomes: a single
surgeon analysis. 31st World Congress of Endourology and SWL, New Orleans, LA, October 24,
2013.

46. Klaassen Z, Cutler C, Ostrowski A, Li Q, Fox PJ, Barrett B, Madi R, Terris MK, Moses KA,
and Lewis RW. A single institution’s utility of using penile Doppler ultrasound to evaluate
erectile dysfunction in patients with prostate cancer. Sexual Medicine Society of North America
19th Annual Fall Meeting, New Orleans, LA, November 21-24, 2013.

47. Klaassen Z, Reinstatler L, Ellington C, Li Q, Madi R, Terris MK, and Moses KA.
Demographics and disease characteristics of patients with undescended vs descended testis germ
cell tumors. 78th Annual Meeting Southeastern Section of the AUA, March 20-23, 2014.

48. Li Q, Cheng M, Klaassen Z, Lee J, Kavuri S, Moses KA, and Terris MK. No value of
microscopic hematuria screening and UroVysionTM for detecting bladder cancer in patients with
previous radiation therapy for prostate cancer. 78th Annual Meeting Southeastern Section of the
AUA, March 20-23, 2014.

49. Klaassen Z, Tatem AJ, King SA, Muller R, Freedland SJ, Terris ML, and Moses KA. Impact
of comorbidity, race and marital status in men referred for prostate biopsy with PSA ≥20ng/ml.
78th Annual Meeting Southeastern Section of the AUA, March 20-23, 2014.

50. Klaassen Z, Burnette JO, Madi R, Terris MK, and Moses KA. 39yo Black male with lower
urinary tract symptoms. T. Leon Howard Imaging Contest. 78th Annual Meeting Southeastern
Section of the AUA, March 20-23, 2014.

51. Reinstatler L, Barrett BL, Klaassen Z, Madi R, Terris MK, and Moses KA. Body mass index,
surgical approach and comorbidity are associated with postoperative renal function among
patients receiving nephrectomy for renal malignancy. 78th Annual Meeting Southeastern Section
of the AUA, March 20-23, 2014.
August 4, 2014

52. Barrett BL, Klaassen Z, Holzman S, Reinstatler L, Madi R, Terris MK, Master VA, and
Moses KA. Multiple discordant histology after nephrectomy: descriptive analysis and outcomes.
78th Annual Meeting Southeastern Section of the AUA, March 20-23, 2014.

53. Klaassen Z, Cutler C, Ostrowski A, Li Q, Fox PJ, Barrett BL, Madi R, Terris MK, Moses
KA, and Lewis RW. A single institution’s utility of using penile Doppler ultrasound to evaluate
erectile dysfunction in patients with prostate cancer. 78th Annual Meeting Southeastern Section
of the AUA, March 20-23, 2014.

54. Klaassen Z, Ellington C, Reinstatler L, Li Q, Madi R, Terris MK, and Moses KA. Lower
socioeconomic status is associated with malignancy in patients with undescended testis.
American Urological Association Meeting, May 2013.

Invited Presentations:
1. Nkx 3.2, a bagpipe Homologue, is Important for the Specification of the Pyloric Sphincter in
Mouse. Pediatric Gastroenterology Grand Rounds, Texas Children’s Hospital, Department of
Pediatrics, Baylor College of Medicine. Houston, TX, March 2002.

2. Advances in Imaging for Bladder Cancer: Challenges in Diagnosis, Staging and Followup.
Genitourinary Multidisciplinary Conference, Karmanos Cancer Institute, Wayne State
University, Detroit, MI. October 2011.

3. Advances in Imaging for Bladder Cancer: Challenges in Diagnosis, Staging and Followup.
Visiting Professor- 10th Annual Georgia Urological Association Spring Meeting, Greensboro,
GA. February 2012.

4. Multimodal Management of Advanced Non-Seminomatous Germ Cell Tumors of the Testis:
The Role of Chemotherapy and RPLND. Visiting Professor- 10th Annual Georgia Urological
Association Spring Meeting, Greensboro, GA. February 2012.

5. Active Surveillance in the Management of Small Renal Masses. 41st Annual Rinker-
Witherington Society Meeting, Georgia Health Sciences University, Augusta, GA. March 2012.

6. Multimodal Management of Advanced Non-Seminomatous Germ Cell Tumors of the Testis:
The Role of Chemotherapy and RPLND. 41st Annual Rinker-Witherington Society Meeting,
Georgia Health Sciences University, Augusta, GA. March 2012.

7. Integration of Chemotherapy and Surgery in the Management of Advanced Testis Cancer.
University of Florida Department of Urology, Gainesville, FL. September 2012.

8. High Risk Prostate Cancer: What Is the Role of Robotic Surgery? Advanced Robotic Surgery
Course, Georgia Regents University, Augusta, GA. March 2013.